SCHEMBL4673000

SCHEMBL4673000

COC(=O)C(C)(C)c1ccc(S)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
BRS3 P32247 1/20 0.43
KCNN4 O15554 1/20 0.42
PLCG1 P19174 1/20 0.37
MAPT P10636 3/20 0.36
ALDH1A1 P00352 4/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 2/20 0.35
SRC P12931 1/20 0.35
LMNA P02545 2/20 0.35
ALOX15 P16050 1/20 0.35
APEX1 P27695 1/20 0.35
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP19A1 P11511 1/20 0.35
ELANE P08246 1/20 0.35
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974321 0.89 CNR1 (0.54) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL5877921 0.83 MAPT (0.50) CNR1CNR2BRS3KCNN4MAPT
SCHEMBL3573740 0.82 CNR1 (0.53) CNR1CNR2BRS3KCNN4MAPT
SCHEMBL1107149 0.82 CNR2 (0.57) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL23583000 0.80 MAPT (0.59) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL363770 0.80 CNR1 (0.51) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL6825088 0.80 POLB (0.50) CNR1CNR2BRS3KCNN4MAPT
SCHEMBL470103 0.80 CNR1 (0.47) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL8187459 0.80 MAPT (0.56) CNR1CNR2MAPTALDH1A1KMT2A
SCHEMBL6628 0.80 KMT2A (0.49) CNR1CNR2BRS3KCNN4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG CNR1 262/4885CNR2 243/4885BRS3 2244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.